Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
10.50
+0.17 (1.70%)
At close: Dec 4, 2025, 4:00 PM EST
10.59
+0.09 (0.89%)
After-hours: Dec 4, 2025, 7:32 PM EST
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $823.26 million as of December 4, 2025. Its market cap has increased by 11.73% in one year.
Market Cap
823.26M
Enterprise Value
578.69M
1-Year Change
11.73%
Ranking
Category
Stock Price
$10.50
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $823.26M, an increase of 76.09%. That is a compound annual growth rate of 7.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 826.01M | -11.37% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 245.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |